Skip to main content
MedPath Trial logoMedPath TrialMedPath Trial Home
Clinical Trials/ISRCTN94220918
ISRCTN94220918CompletedNot Applicable

Multicentric randomised trial concerning the effect of radiotherapy for painful heel spur with very low doses

German Cooperative Group on Radiotherapy for Benign Diseases (GCGBD) (Germany)0 sites200 target enrollmentStarted: July 12, 2007Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
200
Study OverviewEligibility CriteriaInvestigatorsRecords & IdentifiersSimilar Trials

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Sex
All

Inclusion Criteria

  • •1. Clinical proof of a painful heel spur with a duration of anamnesis of more than six months
  • •2. Radiological proof of a heel spur using conventional radiographs
  • •3. Facultatively: Magnetic Resonance Imaging (MRI/MRT), ultrasound, bone scan with proof of an inflammation of the plantar aponeurosis
  • •4. Typical clinical symptoms: tenderness of the calcaneus
  • •5. Typical functional deficits: limitation of the distance that can be walked without pain
  • •6. Aged greater than or equal to 40 years
  • •7. Karnofsky performance index greater than or equal to 70%
  • •8. Written informed consent

Exclusion Criteria

  • •1. Previous radiotherapy to the foot
  • •2. Previous trauma to the foot
  • •3. Additional rheumatic diseases, arterial obturation, severe venous insufficiency, lymphatic oedema of the leg involved
  • •4. Pregnancy, time period of breastfeeding
  • •5. Severe psychiatric disorder
  • •6. Legal incapacitation

Investigators

Sponsor
German Cooperative Group on Radiotherapy for Benign Diseases (GCGBD) (Germany)

Similar Trials

Not yet recruiting
Not Applicable
Multicentric, randomized trial to evaluate the efficacy of baseline Immune-risk stratification based on selective Biomarkers (HLA Eplet mismatching and donor-specific IFN-γ ELISPOT) to optimize Immunosuppressive therapy in Living-kidney transplant patients
NL-OMON49228Academisch Medisch Centrum50
Completed
Not Applicable
The evaluation of the Chinese iSupport for dementia program for caregivers in Australia and Greater ChinaDementia
ACTRN12621000276853ational Foundation for Australia-China Relations204
Active, not recruiting
Not Applicable
Multicentric and randomized study to evaluate the effectiveness of the association of the 2 different treatments in the early P.aerugionsa infection in patient with cystic fibrosis disease. The study will enlist pazients over 5 years old.Cystic fibrosis patients with early P.aeruginosa infection.MedDRA version: 14.1Level: SOCClassification code 10038738Term: Respiratory, thoracic and mediastinal disordersSystem Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders
EUCTR2011-006171-19-ITAZIENDA OSPEDALIERA MEYER
Completed
Not Applicable
Fitness for the Ageing Brain Study II
ACTRN12609000755235The University of Melbourne230
Completed
Phase 3
Efficacy and Safety of Troxipide extended release tablet in patients with gastritis and /or gastric ulcer
CTRI/2012/07/002840Dr Bhupesh Dewan120